Immunoadsorption for heart failure is associated with normalization of iron metabolism

References

• Anderson, G.J. and Frazer, D.M., 2017. Current understanding of iron homeostasis. The American journal of clinical nutrition, 106 (Suppl. 6), 1559S–1566S.
   PubMed Web of Science ®Google Scholar
• Andrews, N.C., 2012. Closing the iron gate. The new England journal of medicine, 366 (4), 376–377.
   PubMed Web of Science ®Google Scholar
• Anker, S.D., et al., 2009. Ferric carboxymaltose in patients with heart failure and iron deficiency. The new England journal of medicine, 361 (25), 2436–2448.
   PubMed Web of Science ®Google Scholar
• Boero, M., et al., 2015. A comparative study of myocardial molecular phenotypes of two tfr2β null mice: role in ischemia/reperfusion. BioFactors (Oxford, England), 41 (5), 360–371.
   PubMed Web of Science ®Google Scholar
• Bunn, H.F. and Aster, J.C., 2011. Pathophysiology of blood disorders. New York: McGraw-Hill Medical.
   Google Scholar
• Chuang, T.-Y., et al., 2020. Combined chelation with high-dose deferiprone and deferoxamine to improve survival and restore cardiac function effectively in patients with transfusion-dependent thalassemia presenting severe cardiac complications. Annals of hematology, 99 (10), 2289–2294.
   PubMed Web of Science ®Google Scholar
• Cohen-Solal, A., et al., 2014. Iron deficiency: an emerging therapeutic target in heart failure. Heart (British cardiac society), 100 (18), 1414–1420.
   PubMed Web of Science ®Google Scholar
• De Domenico, I., et al., 2010. Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. The journal of clinical investigation, 120 (7), 2395–2405.
   PubMed Web of Science ®Google Scholar
• Dong, F., et al., 2005. Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrome c release: involvement of nitric oxide synthase and protein tyrosine nitration. Clinical science (London, England: 1979), 109 (3), 277–286.
   PubMed Web of Science ®Google Scholar
• Fabio, G., et al., 2007. Reversal of cardiac complications by deferiprone and deferoxamine combination therapy in a patient affected by a severe type of juvenile hemochromatosis (JH). Blood, 109 (1), 362–364.
   PubMed Web of Science ®Google Scholar
• Gujja, P., et al., 2010. Iron overload cardiomyopathy: better understanding of an increasing disorder. Journal of the American college of cardiology, 56 (13), 1001–1012.
   PubMed Web of Science ®Google Scholar
• Jankowska, E.A., et al., 2012. Iron status in patients with chronic heart failure. European heart journal, 34 (11), 827–834.
   PubMed Web of Science ®Google Scholar
• Kanamori, Y., et al., 2017. Interleukin-1β (IL-1β) transcriptionally activates hepcidin by inducing CCAAT enhancer-binding protein δ (C/EBPδ) expression in hepatocytes. The journal of biological chemistry, 292 (24), 10275–10287.
   PubMed Web of Science ®Google Scholar
• Markousis‐Mavrogenis, G., et al., 2019. The clinical significance of interleukin‐6 in heart failure: results from the BIOSTAT‐CHF study. European journal of heart failure, 21 (8), 965–973.
   PubMed Web of Science ®Google Scholar
• Nemeth, E., et al., 2003. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood, 101 (7), 2461–2463.
   PubMed Web of Science ®Google Scholar
• Peyssonnaux, C., Nizet, V., and Johnson, R.S., 2008. Role of the hypoxia inducible factors HIF in iron metabolism. Cell cycle (Georgetown, Tex.), 7 (1), 28–32.
   PubMed Web of Science ®Google Scholar
• Ponikowski, P., et al., 2015. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. European heart journal, 36 (11), 657–668.
   PubMed Web of Science ®Google Scholar
• Rhee, J.-W., et al., 2020. Modeling secondary iron overload cardiomyopathy with human induced pluripotent stem cell-derived cardiomyocytes. Cell reports, 32 (2), 107886.
   PubMed Web of Science ®Google Scholar
• Roy, C.N. and Andrews, N.C., 2005. Anemia of inflammation: the hepcidin link. Current opinion in hematology, 12, 107–111.
   PubMed Web of Science ®Google Scholar
• Ruhe, J., et al., 2018. Intrinsic iron release is associated with lower mortality in patients with stable coronary artery disease-first report on the prospective relevance of intrinsic iron release. Biomolecules, 8 (3), 72.
   Web of Science ®Google Scholar
• Seferović, P.M., et al., 2019. Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology. European journal of heart failure, 21 (5), 553–576.
   PubMed Web of Science ®Google Scholar
• Ueda, N. and Takasawa, K., 2018. Impact of inflammation on ferritin, hepcidin and the management of iron deficiency anemia in chronic kidney disease. Nutrients, 10 (9), 1173.
   PubMed Web of Science ®Google Scholar
• Vela, D., 2018. Balance of cardiac and systemic hepcidin and its role in heart physiology and pathology. Laboratory investigation, 98 (3), 315–326.
   PubMed Web of Science ®Google Scholar
• Walter, P.B., et al., 2002. Iron deficiency and iron excess damage mitochondria and mitochondrial DNA in rats. Proceedings of the national academy of sciences of the United States of America, 99 (4), 2264–2269.
   PubMed Web of Science ®Google Scholar
• Weinmann, K., et al., 2018. Add-on immunoadsorption shortly-after optimal medical treatment further significantly and persistently improves cardiac function and symptoms in recent-onset heart failure—a single center experience. Biomolecules, 8 (4), 133.
   Web of Science ®Google Scholar
• Zeller, T., et al., 2018. Prognostic value of iron-homeostasis regulating peptide hepcidin in coronary heart disease—evidence from the Large AtheroGene Study. Biomolecules, 8 (3), 43.
   Web of Science ®Google Scholar
• Zhang, H., et al., 2019. Role of iron metabolism in heart failure: from iron deficiency to iron overload. Biochimica et biophysica acta. Molecular basis of disease, 1865 (7), 1925–1937.
   PubMed Web of Science ®Google Scholar